Eli Lilly and Co (LLY)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$752.67

Buy

$756.50

arrow-down$-2.28 (-0.30%)

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
Prices updated at 19 May 2025, 22:47 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.09%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Profit margins

Created with Highcharts 7.2.2Gross margin (%)Operating margin (%)EBITDA margin (%)Net margin (%)202020212022202320240255075100

Valuation

Created with Highcharts 7.2.2Price earningsPrice / SalesPrice / Cash flow202120222023202420250255075100125

Profit margins data table

YearGross margin (%)Operating margin (%)Net margin (%)EBITDA margin (%)EBITDA
202481.3138.8623.5133.8115,228m
202379.2531.6115.3625.118,568m
202276.7730.3221.8830.348,661m
202174.1828.0119.7128.408,043m
202077.6629.3825.2436.328,913m
201978.8526.8837.2730.916,899m
201878.2228.0415.0425.745,532m
201777.7321.28-1.0220.514,097m
201673.0918.2412.9023.825,056m

Valuation data table

YearPrice / SalesPrice earningsPrice / Cash flow
202513.9661.6373.42
202417.0883.46115.72
202317.25108.8896.85
202211.3655.0143.35
20219.0842.1736.42
20206.6427.6823.18
20195.0829.2129.26
20184.95246.2120.63
20173.9840.2215.21
20163.7531.9822.08
20154.5737.9527.11
Price/Forward earnings (YTD)
34.60

Returns

Created with Highcharts 7.2.2Return on assets (%)Return on equity (%)Return on invested capital (%)20202021202220232024050100150200

Debt profile

Created with Highcharts 7.2.2Financial leverage2020202120222023202402.557.510

Returns data table

YearReturn on assets (%)Return on equity (%)Return on invested capital (%)
202414.8484.8426.47
20239.2348.9317.46
202212.7163.6324.61
202111.7076.3524.39
202014.42150.1832.24
201920.00133.7845.20
20187.2730.1814.56
2017-0.49-1.59-0.68
20167.3619.1611.95

Debt profile data table

YearFinancial leverage
20245.55
20235.94
20224.65
20215.44
20208.27
201915.07
20184.47
20173.88
20162.77
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.